Evidence for Community Transmission of Community-Associated but Not Health-Care-Associated Methicillin-Resistant Strains Linked to Social and Material Deprivation: Spatial Analysis of Cross-sectional Data
Community associated MRSA variants, rather than hospital associated ones, are more readily transmitted and this is where control programs should focus to limit both hospital and community infections.
Vyšlo v časopise:
Evidence for Community Transmission of Community-Associated but Not Health-Care-Associated Methicillin-Resistant Strains Linked to Social and Material Deprivation: Spatial Analysis of Cross-sectional Data. PLoS Med 13(1): e32767. doi:10.1371/journal.pmed.1001944
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001944
Souhrn
Community associated MRSA variants, rather than hospital associated ones, are more readily transmitted and this is where control programs should focus to limit both hospital and community infections.
Zdroje
1. Semenza JC, Giesecke J. Intervening to reduce inequalities in infections in Europe. American journal of public health. 2008;98(5):787–92. doi: 10.2105/AJPH.2007.120329 18381991
2. Semenza JC. Strategies to intervene on social determinants of infectious diseases. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2010;15(27):32–9.
3. Gillespie IA, Mook P, Little CL, Grant KA, McLauchlin J. Human listeriosis in England, 2001–2007: association with neighbourhood deprivation. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2010;15(27):7–16.
4. Bagger JP, Zindrou D, Taylor KM. Postoperative infection with meticillin-resistant Staphylococcus aureus and socioeconomic background. Lancet. 2004;363(9410):706–8. 15001331
5. Commission of the European Communities. White paper. Together for Health: A strategic approach for the EU 2008–2013. Brussels; 2007. http://ec.europa.eu/health-eu/doc/whitepaper_en.pdf
6. Semenza JC, Suk JE, Tsolova S. Social determinants of infectious diseases: a public health priority. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2010;15(27):2–4.
7. Otter JA, French GL. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. The Lancet Infectious diseases. 2010;10(4):227–39. doi: 10.1016/S1473-3099(10)70053-0 20334846
8. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. Jama. 1998;279(8):593–8. 9486753
9. Lowy FD. Staphylococcus aureus infections. New Engl J Med. 1998;339:520–32. 9709046
10. Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. The Journal of hospital infection. 2006;63 Suppl 1:S1–44. 16581155
11. Harbarth S, Sax H, Fankhauser-Rodriguez C, Schrenzel J, Agostinho A, Pittet D. Evaluating the probability of previously unknown carriage of MRSA at hospital admission. The American journal of medicine. 2006;119(3):275 e15-23.
12. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. Jama. 2003;290(22):2976–84. 14665659
13. Egea AL, Gagetti P, Lamberghini R, Faccone D, Lucero C, Vindel A, et al. New patterns of methicillin-resistant Staphylococcus aureus (MRSA) clones, community-associated MRSA genotypes behave like healthcare-associated MRSA genotypes within hospitals, Argentina. International journal of medical microbiology: IJMM. 2014;304(8):1086–99. doi: 10.1016/j.ijmm.2014.08.002 25240872
14. Popovich KJ, Weinstein RA. Commentary: The graying of methicillin-resistant Staphylococcus aureus. Infection control and hospital epidemiology. 2009;30(1):9–12. doi: 10.1086/592709 19046052
15. Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2008;46(6):787–94.
16. Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection. The Journal of hospital infection. 2011;79(3):189–93. doi: 10.1016/j.jhin.2011.04.028 21741111
17. Chua K, Laurent F, Coombs G, Grayson ML, Howden BP. Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA—its evolving antimicrobial resistance and implications for therapy. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2011;52(1):99–114.
18. Millar BC, Loughrey A, Elborn JS, Moore JE. Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA). The Journal of hospital infection. 2007;67(2):109–13. 17669546
19. Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus aureus: the case for a genotypic definition. The Journal of hospital infection. 2012;81(3):143–8. doi: 10.1016/j.jhin.2012.04.009 22622448
20. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. The Lancet Infectious diseases. 2005;5(5):275–86. 15854883
21. Grundmann H, Aanensen DM, van den Wijngaard CC, Spratt BG, Harmsen D, Friedrich AW. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med. 2010;7(1):e1000215. doi: 10.1371/journal.pmed.1000215 20084094
22. Tiemersma EW, Bronzwaer SL, Lyytikainen O, Degener JE, Schrijnemakers P, Bruinsma N, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerging infectious diseases. 2004;10(9):1627–34. 15498166
23. Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, et al. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. The Journal of antimicrobial chemotherapy. 2012;67(4):802–9. doi: 10.1093/jac/dkr561 22223229
24. Derde LP, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJ, Gniadkowski M, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. The Lancet Infectious diseases. 2014;14(1):31–9. doi: 10.1016/S1473-3099(13)70295-0 24161233
25. Lee AS, Cooper BS, Malhotra-Kumar S, Chalfine A, Daikos GL, Fankhauser C, et al. Comparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trial. BMJ open. 2013;3(9):e003126. doi: 10.1136/bmjopen-2013-003126 24056477
26. Harris SR, Cartwright EJ, Torok ME, Holden MT, Brown NM, Ogilvy-Stuart AL, et al. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study. The Lancet Infectious diseases. 2013;13(2):130–6. doi: 10.1016/S1473-3099(12)70268-2 23158674
27. Bastin L, Rollason J, Hilton A, Pillay D, Corcoran C, Elgy J, et al. Spatial aspects of MRSA epidemiology: a case study using stochastic simulation, kernel estimation and SaTScan. Int J Geogr Inf Sci. 2007;21(7):811–36.
28. Gray RR, Tatem AJ, Johnson JA, Alekseyenko AV, Pybus OG, Suchard MA, et al. Testing Spatiotemporal Hypothesis of Bacterial Evolution Using Methicillin-Resistant Staphylococcus aureus ST239 Genome-wide Data within a Bayesian Framework. Mol Biol Evol. 2011;28(5):1593–603. doi: 10.1093/molbev/msq319 21112962
29. Hughes J, Stabler R, Gaunt M, Karadag T, Desai N, Betley J, et al. Clonal variation in high- and low-level phenotypic and genotypic mupirocin resistance of MRSA isolates in south-east London. The Journal of antimicrobial chemotherapy. 2015. dkv248–. doi: 10.1093/jac/dkv248
30. UK Data Service Census Support. Office for National Statistics, 2011 Census: Aggregate data (England and Wales). http://infuse.mimas.ac.uk. Licensed under the terms of the Open Government Licence. [http://www.nationalarchives.gov.uk/doc/open-government-licence/version/2].
31. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–60. doi: 10.1093/bioinformatics/btp324 19451168
32. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. Journal of molecular biology. 1990;215(3):403–10. 2231712
33. Miller CE, Batra R, Cooper BS, Patel AK, Klein J, Otter JA, et al. An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012;54(5):591–600.
34. Office for National Statistics, 2011 Census: Digitised Boundary Data (England and Wales). UK Data Service Census Support. http://www.ons.gov.uk/ons/guide-method/geography/products/census/index.html
35. UK Data Service Census Support. Office for National Statistics. GeoConvert. http://geoconvert.mimas.ac.uk/.
36. English indices of deprivation 2010. Department for Communities and Local Government—Publications—GOV.UK. https://www.gov.uk/government/statistics/english-indices-of-deprivation-2010.
37. Health and Social Care Information Centre (HSCIC). Hospital Episode Statistics. http://www.hscic.gov.uk/hes.
38. Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. J R Stat Soc B. 2009;71:319–92.
39. R Core Team. R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Computing; 2013. http://www.r-project.org/
40. Rue H, Martino S. Approximate Bayesian inference for hierarchical Gaussian Markov random field models. J Stat Plan Infer. 2007;137(10):3177–92.
41. Roos M, Held L. Sensitivity analysis in Bayesian generalized linear mixed models for binary data. Bayesian Anal. 2011;6(2):259–78.
42. Schrodle B, Held L, Riebler A, Danuser J. Using integrated nested Laplace approximations for the evaluation of veterinary surveillance data from Switzerland: a case-study. J R Stat Soc C-Appl. 2011;60:261–79.
43. Blangiardo M, Cameletti M, Baio G, Rue H. Spatial and spatio-temporal models with R-INLA. Spatial and spatio-temporal epidemiology. 2013;7:39–55. 24377114
44. Besag J, York J, Mollie A. Bayesian Image-Restoration, with 2 Applications in Spatial Statistics. Ann I Stat Math. 1991;43(1):1–20.
45. S B. Revisiting Spherical Trigonometry with Orthogonal Projectors. Math Assoc Am Coll Math J. 2004;35:375–81.
46. Bivand R, Lewin-Koh N. Maptools: Tools for reading and handling spatial objects. 2014. http://cran.r-project.org/package=maptools
47. Bivand R, Hauke J, Kossowski T. Computing the Jacobian in Gaussian Spatial Autoregressive Models: An Illustrated Comparison of Available Methods. Geogr Anal. 2013;45(2):150–79.
48. Bivand R, Piras G. Comparing Implementations of Estimation Methods for Spatial Econometrics. J Stat Softw. 2015;63(18):1–36.
49. Rue H MS, Chopin N, Sara Martino NC. Implementing approximate Bayesian inference for latent Gaussian models using integrated nested Laplace approximations: A manual for the inla-program. J R Stat Soc Ser B (Statistical Methodol). 2009(71):319–92.
50. Bjornstad ON. Ncf: spatial nonparametric covariance functions. 2013. http://cran.r-project.org/package=ncf
51. Csardi G NT. The igraph software package for complex network research. InterJournal. 2006;Complex Systems:1695. http://igraph.org
52. Hota B, Ellenbogen C, Hayden MK, Aroutcheva A, Rice TW, Weinstein RA. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Archives of internal medicine. 2007;167(10):1026–33. 17533205
53. Popovich KJ, Smith KY, Khawcharoenporn T, Thurlow CJ, Lough J, Thomas G, et al. Community-associated methicillin-resistant Staphylococcus aureus colonization in high-risk groups of HIV-infected patients. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012;54(9):1296–303.
54. Bratu S, Landman D, Gupta J, Trehan M, Panwar M, Quale J. A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York City. Annals of clinical microbiology and antimicrobials. 2006;5:29. 17137512
55. Casey JA, Cosgrove SE, Stewart WF, Pollak J, Schwartz BS. A population-based study of the epidemiology and clinical features of methicillin-resistant Staphylococcus aureus infection in Pennsylvania, 2001–2010. Epidemiology and infection. 2013;141(6):1166–79. doi: 10.1017/S0950268812001872 22929058
56. Huggan PJ, Wells JE, Browne M, Richardson A, Murdoch DR, Chambers ST. Population-based epidemiology of Staphylococcus aureus bloodstream infection in Canterbury, New Zealand. Internal medicine journal. 2010;40(2):117–25. doi: 10.1111/j.1445-5994.2009.01910.x 19226421
57. Tong SY, van Hal SJ, Einsiedel L, Currie BJ, Turnidge JD. Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in Indigenous Australians. BMC infectious diseases. 2012;12:249. doi: 10.1186/1471-2334-12-249 23043704
58. Tong SY, Bishop EJ, Lilliebridge RA, Cheng AC, Spasova-Penkova Z, Holt DC, et al. Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. The Journal of infectious diseases. 2009;199(10):1461–70. doi: 10.1086/598218 19392622
59. Popovich KJ, Weinstein RA, Aroutcheva A, Rice T, Hota B. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2010;50(7):979–87.
60. Murphy CR, Hudson LO, Spratt BG, Elkins K, Terpstra L, Gombosev A, et al. Predictors of hospitals with endemic community-associated methicillin-resistant Staphylococcus aureus. Infection control and hospital epidemiology. 2013;34(6):581–7. doi: 10.1086/670631 23651888
61. Golding GR, Levett PN, McDonald RR, Irvine J, Nsungu M, Woods S, et al. A comparison of risk factors associated with community-associated methicillin-resistant and -susceptible Staphylococcus aureus infections in remote communities. Epidemiology and infection. 2010;138(5):730–7. doi: 10.1017/S0950268809991488 20092664
62. Johnson AP. Methicillin-resistant Staphylococcus aureus: the European landscape. The Journal of antimicrobial chemotherapy. 2011;66 Suppl 4:iv43–iv8. doi: 10.1093/jac/dkr076 21521706
63. Ellington MJ, Hope R, Livermore DM, Kearns AM, Henderson K, Cookson BD, et al. Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007. The Journal of antimicrobial chemotherapy. 2010;65(3):446–8. doi: 10.1093/jac/dkp448 20035019
64. Edgeworth JD. Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care. The Journal of antimicrobial chemotherapy. 2011;66 Suppl 2:ii41–7. doi: 10.1093/jac/dkq325 20852273
65. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clinical microbiology reviews. 2010;23(3):616–87. doi: 10.1128/CMR.00081-09 20610826
66. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet. 2010;375(9725):1557–68. doi: 10.1016/S0140-6736(09)61999-1 20206987
67. Bartels MD, Kristoffersen K, Boye K, Westh H. Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search and destroy policy. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2010;16(1):78–83.
68. Urth T, Juul G, Skov R, Schonheyder HC. Spread of a methicillin-resistant Staphylococcus aureus ST80-IV clone in a Danish community. Infection control and hospital epidemiology. 2005;26(2):144–9. 15756884
69. Greenland S, Morgenstern H. Ecological bias, confounding, and effect modification. International journal of epidemiology. 1989;18(1):269–74. 2656561
70. Greenland S. Divergent biases in ecologic and individual-level studies. Statistics in medicine. 1992;11(9):1209–23. 1509221
71. Gonzalez BE, Rueda AM, Shelburne SA, 3rd, Musher DM, Hamill RJ, Hulten KG. Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infection control and hospital epidemiology. 2006;27(10):1051–6.
72. Agata EM, Webb GF, Horn MA, Moellering RC, Jr., Ruan S. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2009;48(3):274–84.
73. Skov RL, Jensen KS. Community-associated meticillin-resistant Staphylococcus aureus as a cause of hospital-acquired infections. The Journal of hospital infection. 2009;73(4):364–70. doi: 10.1016/j.jhin.2009.07.004 19786313
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2016 Číslo 1
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial
- Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS)
- Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003–2012
- Between Openness and Privacy in Genomics